What Are the Stages of Small Cell Lung Cancer?

This content has been reviewed and approved by

Chandra P. Belani, MD
Deputy Director, Penn State Cancer Institute
Miriam Beckner Professor of Medicine
Penn State University School of Medicine
 

Stages of cancer relate to how far the cancer has spread in your body. These stages are important to determining the type of treatment you will receive.

The stages of small cell lung cancer are different than for non-small cell lung cancer. A simple staging system is used to separate small cell lung cancer into two stages. The stages are:

  • Limited
  • Extensive

Limited and extensive stages are treated differently. Your oncologist will perform a variety of tests to determine the stage of the disease. This will help in choosing the best treatment. The tests will look for cancer in your bones, abdomen, brain, and bone marrow.

If no cancer is found outside your hemithorax, then you will be diagnosed with limited stage small cell lung cancer (provided it can be encompassed in a radiation port). Otherwise, you will be diagnosed with extensive disease. In many cases, the metastases cannot be detected, and thus accurate staging is of utmost importance.

This content was last modified on November 16, 2007 .
Latest Small Cell Lung Cancer News
Lung cancer in non-smokers a separate disease

October 10, 2008 — NEW YORK (Reuters Health) - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.

Drug combo doesn't boost lung cancer survival

October 6, 2008 — ZURICH/LONDON (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study of the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.

Lilly's Alimta OK'd as front-line lung cancer drug

September 29, 2008 — BOSTON (Reuters) - Eli Lilly and Co on Monday said it has won U.S. approval for its drug Alimta as a first-line treatment for patients with advanced lung cancer.

Select news items provided by Reuters Health